LIANJIE DU: Open Payments
NPI 1255331385 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 28 payments from 5 companies in 2025. Trend: 2023 $857 · 2024 $874 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $433 |
| Teva Pharmaceuticals USA, Inc. | 5 | $222 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
Products named: INGREZZA, UZEDY, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
